Greg Yang, a co-founder of Elon Musk’s artificial intelligence startup xAI, has announced his departure from the company amid health concerns. Yang stated that he has been diagnosed with Lyme disease, which has impacted his ability to continue his duties effectively.
Founded with the goal of advancing AI research, xAI has attracted attention due to Musk’s involvement. Yang joined the company as a key executive, contributing to its development and strategic direction since its inception. His departure marks a significant change for the startup, which aims to compete in the rapidly evolving AI industry.
In a statement, Yang expressed gratitude for the opportunities at xAI and thanked the team for their support. He indicated that his health situation required him to step back from his professional responsibilities to focus on recovery. The company has not disclosed plans for replacing Yang or how his departure might impact ongoing projects.
As of now, xAI continues its work in AI research and development, with the leadership team stating that operations will proceed as planned. The company’s future plans remain unchanged, with an emphasis on innovation in the artificial intelligence sector.